Toll Free: 1-888-928-9744
Published: Nov, 2018 | Pages:
111 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global clinical trial imaging market size is expected to reach USD 1.31 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing spending on research and development activities to develop new drugs and therapies to treat chronic diseases is boosting market growth. Clinical trials assist in the development, registration, and eventually access of new drugs to patients. Imaging helps in the process of drug development by offering non-invasive evaluation of drug action and response of tumor to treatment. Functional imaging techniques are progressively being used in early phases of clinical trials to study initial effects of drug action on parts of tumor biology including metabolism, cellularity, and vascularity. Contract Research Organizations (CROs) were the most prominent end-use segment in the market in 2017. Imaging modalities are used to determine indicators of pharmacological response to a therapy. Biomarkers and surrogate endpoints assist in obtaining quick results with good statistical power even in small sample sizes encouraging CROs to carryout multiple studies with reduced cost of operation. The market in Asia Pacific is projected to witness swift growth during the forecast period as the number of CROs and pharmaceutical organizations in the region are increasing in recent past due to low cost of labor and public and private funding offered in countries such as India and China. However, inaccessibility of trial protocols and poor quality of registered clinical trial data, results, and participant-level data undermined the potential benefits of clinical trial registration earlier. Nevertheless, emergence of national and regional registries and ICTRP have facilitated to overcome aforementioned barriers in APAC. Further key findings from the report suggest: • North America dominated the market in 2017. Attaining compliance with registration requires a combination of international and local measures and remains a key challenge in many countries. However, U.S. FDA and other regulatory organizations have played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future • Some of the players operating in this market are Parexel International Corporation; Intrinsic Imaging; Radiant Sage; Icon PLC; Worldcare Clinical; Bioclinica Inc.; Navitas Life Sciences; Resonance Health; Ixico PLC; and Medpace.
Table of Contents Chapter 1 Report Scope 1.1 Segment Market Scope 1.2 Regional Scope 1.3 Estimates and Forecast Timeline Chapter 2 Methodology 2.1 Research Methodology 2.1.1 Information procurement 2.2 Information or Data Analysis 2.3 Market Formulation & Validation 2.4 Region Wise Market Calculation 2.4.1 Region Wise Market: Base Estimates 2.4.2 Global Market: CAGR Calculation 2.5 Region Based Segment Share Calculation 2.6 Model Details 2.6.1 Commodity flow analysis (Model 1) 2.6.2 Volume price analysis (model 2) 2.7 List of Secondary Sources 2.8 List of Primary Sources 2.9 List of Abbreviations Chapter 3 Objectives 3.1 Objective - 1: Understanding the market dynamics 3.2 Objective - 2: Understanding the market estimates and forecasts 3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization 3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes Chapter 4 Executive Summary Chapter 5 Market Definition Chapter 6 Industry Outlook 6.1 Market Segmentation 6.2 Business Segment Trends 6.2.1 Product business analysis 6.2.2 Regional business analysis 6.3 Market Variable Analysis 6.3.1 Market driver analysis 6.3.1.1 Increasing demand for cosmetic dentistry 6.3.1.2 Growing prevalence of dental ailments 6.3.1.3 Increasing number of dental surgeries 6.3.2 Market restraint analysis 6.3.2.1 Stringent regulations on dental device sterilization 6.4 Business Environment Analysis tools 6.4.1 SWOT Analysis, by PEST 6.4.2 Porter's five forces analysis 6.4.3 Industry Analysis - Ansoff Matrix Chapter 7 Competitive & Vendor Landscape 7.1 Participant Categorization 7.2 Strategy Mapping Chapter 8 Clinical Trial Imaging Market: Service Estimates & Trend Analysis 8.1 Clinical Trial Imaging Market: Service Movement Analysis 8.2 Clinical Trial Design and Consultation 8.2.1 Clinical trial design and consultation market estimates and forecasts, 2014 - 2026 (USD Million) 8.3 Reading and Analytical 8.3.1 Reading and analytical market estimates and forecasts, 2014 - 2026 (USD Million) 8.4 Operational Imaging 8.4.1 Operational imaging market estimates and forecasts, 2014 - 2026 (USD Million) 8.5 System and Technology Support 8.5.1 System and technology support market estimates and forecasts, 2014 - 2026 (USD Million) 8.6 Project and Data Management 8.6.1 Project and data management market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 9 Clinical Trial Imaging Market: Modalities Estimates & Trend Analysis 9.1 Clinical Trial Imaging Market: Service Movement Analysis 9.2 Computed Tomography (CT) Scan 9.2.1 Computed Tomography (CT) Scan market estimates and forecasts, 2014 - 2026 (USD Million) 9.3 Magnetic Resonance Imaging (MRI) 9.3.1 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2014 - 2026 (USD Million) 9.4 X-Ray 9.4.1 X-Ray market estimates and forecasts, 2014 - 2026 (USD Million) 9.5 Ultrasound 9.5.1 Ultrasound market estimates and forecasts, 2014 - 2026 (USD Million) 9.6 Optical Coherence Tomography (OCT) 9.6.1 Optical Coherence Tomography (OCT) market estimates and forecasts, 2014 - 2026 (USD Million) 9.7 Others 9.7.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 10 Clinical Trial Imaging Market: End-use Estimates & Trend Analysis 10.1 Clinical Trial Imaging Market: End-use Movement Analysis 10.2 Biotechnology and Pharmaceutical Companies 10.2.1 Biotechnology and Pharmaceutical companies market estimates and forecasts, 2014 - 2026 (USD Million) 10.3 Medical Devices Manufacturers 10.3.1 Medical Devices Manufacturers market estimates and forecasts, 2014 - 2026 (USD Million) 10.4 Academic and government research institutes 10.4.1 Academic and government research institutes market estimates and forecasts, 2014 - 2026 (USD Million) 10.5 Contract Research Organization (CROs) 10.5.1 Contract Research Organization (CROs) market estimates and forecasts, 2014 - 2026 (USD Million) 10.6 Others 10.6.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 11 Clinical Trial Imaging Market: Regional Estimates & Trend Analysis 11.1 Clinical Trial Imaging Market Share by Region, 2017 & 2026 11.2 North America 11.2.1 North America clinical trial imaging market, 2014 - 2026 (USD Million) 11.2.2 U.S. 11.2.2.1 U.S. clinical trial imaging market, 2014 - 2026 (USD Million) 11.2.3 Canada 11.2.3.1 Canada clinical trial imaging market, 2014 - 2026 (USD Million) 11.3 Europe 11.3.1 Europe clinical trial imaging market, 2014 - 2026 (USD Million) 11.3.2 U.K. 11.3.2.1 U.K. clinical trial imaging market, 2014 - 2026 (USD Million) 11.3.3 Germany 10.3.3.1 Germany clinical trial imaging market, 2014 - 2026 (USD Million) 11.4 Asia Pacific 11.4.1 Asia Pacific clinical trial imaging market, 2014 - 2026 (USD Million) 11.4.2 Japan 11.4.2.1 Japan clinical trial imaging market, 2014 - 2026 (USD Million) 11.4.3 China (Mainland) 11.4.3.1 China (Mainland) clinical trial imaging market, 2014 - 2026 (USD Million) 11.5 Latin America 11.5.1 Latin America clinical trial imaging market, 2014 - 2026 (USD Million) 11.5.2 Brazil 11.5.2.1 Brazil clinical trial imaging market, 2014 - 2026 (USD Million) 11.5.3 Mexico 11.5.3.1 Mexico clinical trial imaging market, 2014 - 2026 (USD Million) 11.6 MEA 11.6.1 MEA clinical trial imaging market, 2014 - 2026 (USD Million) 11.6.2 South Africa 11.6.2.1 South Africa clinical trial imaging market, 2014 - 2026 (USD Million) 11.6.3 Saudi Arabia 11.6.3.1 Saudi Arabia clinical trial imaging market, 2014 - 2026 (USD Million) Chapter 12 Company Profiles 12.1 Company Profiles 12.1.1 Bioclinica 12.1.1.1 Company overview 12.1.1.2 Financial performance 12.1.1.3 Product benchmarking 12.1.1.4 Strategic initiatives 12.1.2 ICON 12.1.2.1 Company overview 12.1.2.2 Financial performance 12.1.2.3 Product benchmarking 12.1.2.4 Strategic initiatives 12.1.3 IXICIO 12.1.3.1 Company overview 12.1.3.2 Financial performance 12.1.3.3 Product benchmarking 12.1.3.4 Strategic initiatives 12.1.4 Navitas life sciences 12.1.4.1 Company Overview 12.1.4.2 Financial performance 12.1.4.3 Product benchmarking 12.1.4.4 Strategic initiatives 12.1.5 Resonance Health 12.1.5.1 Company overview 12.1.5.2 Financial performance 12.1.5.3 Product benchmarking 12.1.5.4 Strategic initiatives 12.1.6 Worldcare Clinical 12.1.6.1 Company overview 12.1.6.2 Financial performance 12.1.6.3 Product benchmarking 12.1.6.4 Strategic initiatives 12.1.7 Intrinsic Imaging 12.1.7.1 Company overview 12.1.7.2 Financial performance 12.1.7.3 Product benchmarking 12.1.7.4 Strategic initiatives 12.1.8 Radiant Sage 12.1.8.1 Company overview 12.1.8.2 Financial performance 12.1.8.3 Product benchmarking 12.1.8.4 Strategic initiatives 12.1.9 Parexel International corporation 12.1.9.1 Company overview 12.1.9.2 Financial performance 12.1.9.3 Product benchmarking 12.1.9.4 Strategic initiatives 12.1.10 Medpace 12.1.10.1 Company overview 12.1.10.2 Financial performance 12.1.10.3 Product benchmarking 12.1.10.4 Strategic initiatives
List of Tables Table 1 List of secondary sources Table 2 List of Abbreviation Table 3 Leading market players anticipated to witness highest growth Table 4 Global Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 5 Global Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 6 Global Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 7 Global Clinical Trial Imaging Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million) Table 8 North America Clinical Trial Imaging Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million) Table 9 North America Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 10 North America Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 11 North America Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 12 U.S. Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 13 U.S. Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 14 U.S. Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 15 Canada Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 16 Canada Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 17 Canada Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 18 Europe Clinical Trial Imaging Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million) Table 19 Europe Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 20 Europe Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 21 Europe Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 22 U.K. Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 23 U.K. Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 24 U.K. Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 25 Germany Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 26 Germany Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 27 Germany Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 28 Asia Pacific Clinical Trial Imaging Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million) Table 29 Asia Pacific Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 30 Asia Pacific Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 31 Asia Pacific Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 32 Japan Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 33 Japan Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 34 Japan Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 35 China Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 36 China Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 37 China Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 38 Latin America Clinical Trial Imaging Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million) Table 39 Latin America Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 40 Latin America Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 41 Latin America Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 42 Mexico Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 43 Mexico Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 44 Mexico Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 45 Brazil Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 46 Brazil Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 47 Brazil Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 48 MEA Clinical Trial Imaging Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million) Table 49 MEA Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 50 MEA Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 51 MEA Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 52 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 53 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 54 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million) Table 55 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by Service 2014 - 2026 (USD Million) Table 56 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by Modalities 2014 - 2026 (USD Million) Table 57 South Africa Clinical Trial Imaging Market Estimates & Forecasts, by End-use 2014 - 2026 (USD Million)
List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value chain based sizing & forecasting Fig. 6 QFD modelling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Clinical Trial Imaging market segmentation Fig. 9 Market driver relevance analysis (Current & future impact) Fig. 10 Market restraint relevance analysis (Current & future impact) Fig. 11 SWOT analysis, by factor (political & legal, economic and technological) Fig. 12 Porter's five forces analysis Fig. 13 Ansoff matrix analysis Fig. 14 Heat map analysis Fig. 15 Strategy mapping Fig. 16 Clinical trial imaging market service outlook: key takeaways Fig. 17 Clinical Trial Imaging market: Service movement analysis Fig. 18 Clinical trial design and Consultation market, 2014 - 2026 (USD Million) Fig. 19 Reading and analytical market, 2014 - 2026 (USD Million) Fig. 20 Operational imaging market, 2014 - 2026 (USD Million) Fig. 21 System and technology support market, 2014 - 2026 (USD Million) Fig. 22 Project and data management market, 2014 - 2026 (USD Million) Fig. 23 Clinical Trial Imaging market modalities outlook: Key takeaways Fig. 24 Clinical Trial Imaging market: Modalities movement analysis Fig. 25 Computed Tomography Scan market, 2014 - 2026 (USD Million) Fig. 26 Magnetic Resonance Imaging (MRI) market, 2014 - 2026 (USD Million) Fig. 27 X-Ray market, 2014 - 2026 (USD Million) Fig. 28 Ultrasound market, 2014 - 2026 (USD Million) Fig. 29 Optical Coherence Tomography (OCT) market, 2014 - 2026 (USD Million) Fig. 30 Others market, 2014 - 2026 (USD Million) Fig. 31 Clinical Trial Imaging market end-use outlook: Key takeaways Fig. 32 Clinical Trial Imaging market: End-use movement analysis Fig. 33 Biotechnology and pharmaceutical companies market, 2014 - 2026 (USD Million) Fig. 34 Medical devices manufacturers market, 2014 - 2026 (USD Million) Fig. 35 Academic and government research institutes market, 2014 - 2026 (USD Million) Fig. 36 Contract Research Organization (CROs) market, 2014 - 2026 (USD Million) Fig. 37 Others market, 2014 - 2026 (USD Million) Fig. 38 Clinical Trial Imaging market regional outlook: Key takeaways Fig. 39 Clinical Trial Imaging market: Regional movement analysis Fig. 40 North America clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 41 U.S clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 42 Canada clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 43 Europe clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 44 U.K. clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 45 Germany clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 46 Asia Pacific clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 47 China clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 48 Japan clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 49 Latin America clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 50 Brazil clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 51 Mexico clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 52 MEA clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 53 South Africa clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 54 Saudi Arabia clinical trial imaging market, 2014 - 2026 (USD Million) Fig. 55 Strategy framework
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.